Neuberger Berman Group LLC Alkermes Plc. Transaction History
Neuberger Berman Group LLC
- $123 Billion
- Q3 2024
A detailed history of Neuberger Berman Group LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 12,199 shares of ALKS stock, worth $354,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,199
Previous 14,177
13.95%
Holding current value
$354,258
Previous $341,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ALKS
# of Institutions
363Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$845 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$551 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$377 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$368 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$267 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.77B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...